Literature DB >> 9468279

Novel monoclonal antibodies against membrane structures that are preferentially expressed on IL-2-activated rat NK cells.

K M Giezeman-Smits1, L E Jonges, W H Chambers, C S Brisette-Storkus, R L Van Vlierberghe, J D Van Eendenburg, A M Eggermont, G J Fleuren, P J Kuppen.   

Abstract

Interleukin-2 (IL-2)-activated natural killer (NK) cells are known to mediate specific functions such as cytolytic activity and tumor infiltration more efficiently than nonactivated NK cells. To investigate whether these characteristics are associated with induction or up-regulation of expression of membrane structures after IL-2 activation, we selected four hybridomas (mAbs ANK44, ANK66, ANK7, and ANK123) derived from mice immunized with rat IL-2-activated NK cells and compared the expression of the epitopes recognized on IL-2-activated NK cells versus unstimulated NK cells. We found that ANK44-expression was induced after activation with IL-2. The antigens recognized by ANK66, ANK7, and ANK123 were expressed selectively on subsets of nonactivated NK cells. After activation with IL-2 the level of expression of these antigens was increased. Moreover, the majority of NK cells then expressed these antigens after IL-2 activation. Biochemical characterization of the membrane structures recognized on IL-2-activated NK cells showed that they have not previously been described. The precise function of these membrane structures is not yet known, however, the selective nature of their expression implies their involvement in the specific functions of IL-2-activated NK cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9468279     DOI: 10.1002/jlb.63.2.209

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  5 in total

1.  Interleukin-4 supplementation improves the pathophysiology of hypertension in response to placental ischemia in RUPP rats.

Authors:  Jesse N Cottrell; Lorena M Amaral; Ashlyn Harmon; Denise C Cornelius; Mark W Cunningham; Venkata Ramana Vaka; Tarek Ibrahim; Florian Herse; Gerd Wallukat; Ralf Dechend; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-01-09       Impact factor: 3.619

2.  17-Hydroxyprogesterone caproate improves T cells and NK cells in response to placental ischemia; new mechanisms of action for an old drug.

Authors:  Jamil T Elfarra; Jesse N Cottrell; Denise C Cornelius; Mark W Cunningham; Jessica L Faulkner; Tarek Ibrahim; Babbette Lamarca; Lorena M Amaral
Journal:  Pregnancy Hypertens       Date:  2019-12-02       Impact factor: 2.899

3.  Natural killer cells mediate pathophysiology in response to reduced uterine perfusion pressure.

Authors:  Jamil Elfarra; Lorena M Amaral; Maggie McCalmon; Jeremy D Scott; Mark W Cunningham; Ashley Gnam; Tarek Ibrahim; Babbette LaMarca; Denise C Cornelius
Journal:  Clin Sci (Lond)       Date:  2017-11-23       Impact factor: 6.124

4.  AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic Rats.

Authors:  Mark W Cunningham; Javier Castillo; Tarek Ibrahim; Denise C Cornelius; Nathan Campbell; Lorena Amaral; Venkata Ramana Vaka; Nathan Usry; Jan M Williams; Babbette LaMarca
Journal:  Hypertension       Date:  2018-03-19       Impact factor: 10.190

5.  Progesterone-induced blocking factor improves blood pressure, inflammation, and pup weight in response to reduced uterine perfusion pressure (RUPP).

Authors:  Jesse N Cottrell; Alexis C Witcher; Kyleigh Comley; Mark W Cunningham; Tarek Ibrahim; Denise C Cornelius; Babbette LaMarca; Lorena M Amaral
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-02-03       Impact factor: 3.210

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.